Please Note:
This profile was automatically generated using 20 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 20 references found on the Internet. This information has not been verified. Learn more...
View all 20 references Web References
-
1. www.sec.gov
www.sec.gov/Archives/edgar/dat - [Cached]Published on: 6/5/2008 Last Visited: 6/6/2008
Kenneth Collins(1)
...
Kenneth A. Collins, M.B.B.S., has been Alsius's Executive Vice President of Regulatory, Clinical, Quality Assurance and Research and Development since October 2003.From January 2001 until September 2003, Dr. Collins served as Alsius's Vice President of Clinical, Quality and Regulatory Affairs.From February 1998 until November 2000, he held senior management and consulting positions at Boston Scientific Corporation, a publicly traded diversified medical device company.Dr. Collins earned an M.B.B.S. from Sydney University Medical School and an MBE from University of New South Wales. -
2. Management Team: Alsius.com
www.alsius.com/company/managem - [Cached]Published on: 3/18/2008 Last Visited: 3/18/2008
Ken Collins, B.Sc. (Med.), M.B.B.S., M. Biomed. E Executive Vice President of Regulatory, Clinical, Quality and R&D Dr. Collins has 15 years of experience in the medical device field. He held senior management positions at Telectronics Pacing Systems and Boston Scientific prior to joining ALSIUS. Dr. Collins has been involved in the research and development of implantable defibrillators and has held senior positions ranging from operations to product development primarily in class II and class III medical devices. He is a graduate of Sydney University Medical School and has a master's degree in biomedical engineering. -
3. www.sec.gov
www.sec.gov/Archives/edgar/dat - [Cached]Published on: 6/8/2007 Last Visited: 6/9/2007
After the consummation of the merger, Paul A. Brooke will be chairman of the board of Ithaka and the executive officers will be William J. Worthen, as chief executive officer, Brett L. Scott, as chief financial officer, and each of Kenneth A. Collins, H. Michael Ameli and Suzanne C. Winter, as executive vice presidents.
...
Worthen, Scott, Collins, Ameli and Ms. Winter currently is an executive officer of Alsius and will continue in such position after the merger.
...
Kenneth A. Collins, M.B.B.S
...
Kenneth A. Collins, M.B.B.S., has been Alsius's Executive Vice President of Regulatory, Clinical, Quality and Research and Development since October 2003. From January 2001 until September 2003, Dr. Collins served as Alsius's Vice President of Clinical, Quality and Regulatory Affairs. From February 1998 until November 2000, he held senior management and consulting positions at Boston Scientific Corporation, a publicly traded diversified medical device company. Dr. Collins earned an M.B.B.S. from Sydney University Medical School and an MBiomedE from University of New South Wales.
...
After the consummation of the merger, Paul A. Brooke will be chairman of the board of Ithaka and the executive officers will be William J. Worthen, as chief executive officer, Brett L. Scott, as chief financial officer, and each of Kenneth A. Collins, H. Michael Ameli and Suzanne C. Winter, as executive vice presidents.
...
Worthen, Scott, Collins, Ameli and Ms. Winter currently is an executive officer of Alsius and will continue in such position after the merger.
...
Kenneth A. Collins - Executive Vice President
...
Kenneth A. Collins - Executive Vice President

